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Abstract
Background: Insulin secreted by pancreatic islet b-cells is the principal regulating hormone of glucose metabolism
and plays a key role in controlling glucose level in blood. Impairment of the pancreatic islet function may cause
glucose to accumulate in blood, and result in diabetes mellitus. Recent studies have shown that mitochondrial
dysfunction has a strong negative effect on insulin secretion.
Methods: In order to study the cause of dysfunction of pancreatic islets, a multiple cell model containing healthy
and unhealthy cells is proposed based on an existing single cell model. A parameter that represents the function
of mitochondria is modified for unhealthy cells. A 3-D hexagonal lattice structure is used to model the spatial
differences among b-cells in a pancreatic islet. The b-cells in the model are connected through direct electrical
connections between neighboring b-cells.
Results: The simulation results show that the low ratio of total mitochondrial volume over cytoplasm volume per
b-cell is a main reason that causes some mitochondria to lose their function. The results also show that the overall
insulin secretion will be seriously disrupted when more than 15% of the b-cells in pancreatic islets become
unhealthy.
Conclusion: Analysis of the model shows that the insulin secretion can be reinstated by increasing the
glucokinase level. This new discovery sheds light on antidiabetic medication.
Background
With 25-30 percent of adults in the developed world hav-
ing a high risk of diabetes, and 24 million people in the
United States with diabetes, diabetes mellitus ranks as a
principal cause of death [1]. The incidence of diabetes
mellitus is expected to double within the coming 20 years.
After a meal, healthy individuals secrete insulin into the
bloodstream signaling the consumption of glucose pro-
duced from the digested food. Thus insulin has an impor-
tant signaling role in the maintenance of low blood
glucose levels via glucose consumption. Type II diabetes
may result from disruption of this signaling process [2,3].
Hence understanding the insulin secretion mechanism is
vitally important.
The main pathways involved in glucose-stimulated insu-
lin secretion are shown in Figure 1. Glucose is imported
into b-cells and undergoes the glycolysis process. Three pri-
mary products, pyruvate, malate, and nicotinamide adenine
dinucleotide plus hydrogen (NADH), are produced in gly-
colysis [4] and transported into mitochondria. In mitochon-
dria pyruvate and malate are consumed in the tricarboxylic
acid (TCA) cycle to produce fumarate. Adenosine tripho-
sphate (ATP), the most important energy resource in the
cell, is produced from fumarate and NADH through oxida-
tive phosphorylation and released to the cytoplasm [5]. The
increasing ATP level in the cytoplasm blocks the ATP-sen-
sitive K+ channel [6-8], resulting in a higher intracellular K+
level and depolarization of the cell membrane. This results
in the opening of voltage-dependent Ca2+ channels. Cyto-
plasmic Ca2+ is transported into the b-cell from the extra-
cellular fluid through the voltage-gated Ca2+ channels
[9-11]. When both the cytoplasmic ATP and Ca2+ levels
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rise high enough, the vesicles containing insulin fuse with
the cell plasma membrane, releasing insulin from the cell.
The increasing formation and export of ATP to the entire
cell will raise the Ca2+ levels in the mitochondria as well.
High mitochondrial Ca2+ levels eventually collapse the
mitochondrial membrane potential, shutting off ATP pro-
duction, possibly by opening a low-conductance state of
the permeability transition pore (PTP) in the mitochondrial
membrane [12-14]. The rise and fall in the mitochondrial
membrane potential and intramitochondrial Ca2+ concen-
tration is the mitochondrial oscillation. The frequency of
this oscillation depends on how rapidly the mitochondria
can build up its membrane potential and transport Ca2+.
Besides the metabolic pathway in a single b-cell, cells in
each pancreatic islet are also connected through direct elec-
trical connections between neighboring b-cells. This con-
nection is sufficient to synchronize both electrical bursting
activity and metabolic oscillations [15].
The cells, in fact, have differing capabilities in consum-
ing glucose, since their differing physical properties cause
different rates of electron transport chain function, ATP
production, Ca2+ uptake and release, and cell membrane
potential. Furthermore, some b-cells do not function nor-
mally as just described. The term unhealthy is used to
describe cells that cannot consume glucose normally.
Unhealthy cells interact strongly with adjacent healthy
cells, because of their electrical connections. The total
insulin secretion is the aggregation of the insulin secreted
by all pancreatic islet cells. Its dynamics may be destroyed
by a small fraction of unhealthy cells even though a large
majority of the cells are still healthy. Consequently, under-
standing how a cohort of unhealthy cells can affect the
insulin secretion process in other healthy cells is very
important, and can lead to a better understanding of the
cause of diabetes.
This present work proposes a mathematical model to
study scenarios with unhealthy cells leading to insulin
oscillation failure. The new model is based on a mathe-
matical insulin secretion model of the oscillation and
metabolic pathway of insulin secretion in a single b-cell,
due to Bertram et al. [16-18]. Bertram’s original model is
extended to model spatial and coupling effects [14] due
to the electrical connections between neighboring b-cells.
Mitochondrial dysfunction is believed to have a strong
negative effect on insulin secretion [19-21], and also
mitochondrial dysfunction is believed to be a main cause
of unhealthy cells, based on the recent data of [22-24].
The ratio of the total mitochondrial volume to the cyto-
plasm volume per b-cell, a parameter corresponding to
mitochondria function, is used to define unhealthy cells,
as distinguished from healthy cells. The effect on the islet
insulin oscillation of unhealthy cells coupled with healthy
cells is then studied in detail. Multiple cell simulations
demonstrate insulin oscillation malfunction when the
fraction of unhealthy cells exceeds approximately 15%.
To verify this result, a simplified coupling topology is
used to study the effect of one unhealthy cell on neigh-
boring healthy cells. The latter study confirmed the pre-
vious more complicated simulation.
In order to understand the cause of insulin secretion
failure resulted from unhealthy cells, an eight-cell model
is built and studied in details. We discovered a critical
difference of the dynamics between healthy cells and
unhealthy cells. Our simulation results demonstrate that
stimulating glucokinase can make unhealthy pancreatic
islets function normally. Based on the discovery, a possi-
ble strategy for antidiabetic medicine is proposed. Our
strategy is consistent with recent antidiabetic medicine




The mathematical model of a single pancreatic b-cell is
based on the deterministic model introduced by Bertram
et al. [16-18]. The model has four components: glycolytic,
mitochondrial metabolism, cytoplasmic intermediate, and
plasma membrane. Each component of the model is con-
nected by variables shared between components as illu-
strated in Figure 2.
The glycolytic component of the model is a simplified
model of the glycolysis pathway [31] that converts glu-
cose into pyruvate. This pathway generates oscillations
via a critical enzyme phosphofructokinase (PFK), the rate
limiting variable in glycolysis and an important control.
PFK is allosterically inhibited by ATP [32]. As a result
high ATP levels will cause glycolysis to slow down. PFK
phosphorylates fructose-6-phosphate (F6P) to fructose-
1,6-bisphosphate (FBP), which is a substrate for glycera-
dehyde 3-P dehydrogenase (GPDH). The GPDH reaction
is in a rapid equilibrium, therefore used as the input to
Figure 1 Metabolic pathway in the b-cell.
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the mitochondrial component, replacing pyruvate dehy-
drogenase (PDH) in the model. The glycolysis model
consists of equations for the concentrations [G6P] and
[FBP]. Here [G6P] is the glucose 6-phosphate concentra-
tion, which is assumed to be in rapid equilibrium with
[F6P], and the Js are fluxes.
d[G6P]
dt
= JGK − JPFK , (1a)
d[FBP]
dt
= JPFK − 12 JGPDH. (1b)
The model for the mitochondrial component is based on
the detailed Magnus-Keizer model of mitochondrial meta-
bolism [33]. The tricarboxylic acid cycle (TCA cycle) and
oxidative phosphorylation occur in mitochondria. The
TCA cycle is a series of enzyme-catalyzed chemical reac-
tions whose main role is to convert pyruvate to NADH
and reduced flavin adenine dinucleotide (FADH), and
then feed them into oxidative phosphorylation, which uses
energy released by the oxidation of nutrients to produce
ATP [34]. The model includes an expression for Ca2+-
dependent dehydrogenases of the citric acid cycle, yielding
NADH. The NADH supplies electrons for the electron
transport chain, which produces a membrane potential Δψ
across the mitochondrial inner membrane. The flux of
protons down the electrical gradient through the F1F0-
ATP synthase converts ADP to ATP. Finally, Ca2+ enters
the mitochondria through Ca2+ uniporters and is trans-
ported out through Na+/Ca2+ exchangers [35]. The mito-
chondrial compartment has variables for the NADH,
ADP, and mitochondrial Ca2+ concentrations, and for Δψ
The ATP concentration is calculated from the ADP con-
centration by assuming that the sum of the two is con-




= γ (JDH − JO), (2a)
d ψ
dt
= (JH,Res − JH,atp − JANT − JH,leak − JNaCa − 2Juni)/Cm, (2b)
d[Cam]
dt
= fm(Juni − JNaCa), (2c)
d[ADPm]
dt
= γ (JANT − JF1F0). (2d)
There are five variables in the cytoplasmic intermediate
and plasma membrane components, which describe the
plasma membrane potential V and the cytosolic ADP con-
centration, the fraction n of the opened delayed rectifying
K+ channels and cytosolic Ca2+ concentration, as well as
the ER Ca2+ concentration. The differential equations are
dV
dt









= fc(Jmem + Jer + κJm), (3c)
d[Caer]
dt
= −fer(Vc/Ver)Jer , (3d)
d[ADPc]
dt
= Jhyd − κJANT , (3e)
where IK, ICa, IK(Ca), and IK(ATP) are the ionic current on
the membrane, C is the membrane capacitance, fc is the
fraction of free Ca2+ in the cytosol, Jmem is the flux of Ca
2+
Figure 2 Model components and interconnections. The whole model is divided into four components: glycolytic, mitochondrial metabolism,
cytoplasmic intermediate, and plasma membrane.
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across the plasma membrane, Jm is the flux of Ca
2+ out of
the mitochondria, which is scaled by the mitochondria/
cytosol volume ratio , Jer is the flux out of the ER, fer is the
fraction of free Ca2+ in the ER, Vc and Ver are the volumes
of the cytosolic and ER compartments, respectively, n is the
fraction of the open delayed rectifying K+ channels, τ is the
relaxation time for the open and close reactions of the
delayed rectifying K+ channels to reach equilibrium, and
the steady state function for n is n∞(V) = (1 + exp(−(V +
16)/5))−1. For more details on these terms in the differential
equations of the model, refer to Bertram et al.
Multiple b-cells modeling
There are about 1, 000 b-cells in each pancreatic islet.
They interact with neighboring b-cells through direct
electrical connections. These interactions are modeled
with a change in (3a):
dVj
dt






where Ij is the current for cell j, gc is the electrical cou-
pling conductance, and N (j) is the index set for all neigh-
bor cells of cell j. The neighbors surrounding a cell j are
detected by considering the position of a cell j within a
3-D hexagonal lattice (different from the 3-D von Neu-
mann neighborhoods of cellular automata theory). As
shown in Figure 3, each internal cell is connected with six
Figure 3 Three layers of b-cells in 3-D hexagonal lattice.
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cells in the same layer, three cells in the upper layer and
three other cells in the lower layer. For example, cell 23 in
Figure 3 is connected with cells 18, 19, 22, 24, 27, 28 in its
own layer, and connected with cells 7, 11, 12 in the upper
layer, and cells 34, 35, 39 in the lower layer. Face, edge,
and corner cells have between three and nine neighbors,
depending on their location. Table 1 is used to calculate
the coordinates of the neighbors of cell (a, b, c) in the 3-D
hexagonal lattice.
Besides the spatial differences, each cell has its own
parameter set. Among all the parameters of the single
cell model, , the ratio of mitochondria volume to cytosol
volume, represents the function of mitochondria. The
single cell study has shown that the oscillation behavior
of a cell is very sensitive to , and thus  is used to
describe the cell differences. The value of  is different
for each cell in the 3-D structure, while all other cell
parameters are set the same.
Results and discussion
The differential equations for the model, implemented in
Fortran 90, were solved using LSODE in ODEPACK [36].
Generated data were plotted using Matlab. The simulations
are performed on a Mac OS 2.4 GHz Intel(R) Core 2 Duo
CPU with 4GB memory.
Single b-cell simulation
The simulation model for multiple cells has at its core the
single cell model. Since the total amount of ATP and ADP
(in the single cell model) is conserved, only ADP appears
in the differential equation
d[ADPc]
dt
= Jhyd − κJANT , (5)
where Jhyd is the hydrolysis rate of ATP to ADP,  ( =
0.0733 in the standard model [37]) is the ratio of the total
functional mitochondrial volume to the cytoplasm volume,
and JANT is the flux through the adenine nucleotide trans-
locator, which exchanges ADP and ATP molecules
between the cytoplasm and the mitochondria. With  =
0.0733, both the cell membrane potential and insulin
secretion show periodic bursts of rapid oscillation, as illu-
strated in Figure 1 of Additional file 1. The slowest com-
ponent of the compound bursting is due to oscillatory
glycolysis, reflected by an oscillatory FBP concentration.
The oscillatory glycolysis causes slow oscillations in ADP,
which superimpose with the faster ADP oscillations driven
by Ca2+. The multimodal ADP rhythm leads to oscillations
in the conductance of the ATP-dependent potassium
channel, which drives the burst episodes of the membrane
potential V, which then results in compound bursting of
intracellular calcium, leading to pulsatile insulin secretion.
In truth, though,  varies between cells; specifically, cells
with some mitochondria weakened due to aging will
effectively have a  smaller than the default value. It is
therefore paramount to study the sensitivity of the cell
membrane potential V and insulin secretion I patterns to
the parameter . For this work, Bertram’s single cell
model is modified by varying the parameter  to represent
different levels of functional mitochondria within different
cells. In terms of changes in the patterns of V, Ca2+, and I,
the bursting behavior of the model is classified into four
categories as a function of the volume of functioning mito-
chondria in the b-cell, in order of occurrence: burst forma-
tion, periodic burst, burst loss, and decoupling.
The bursting pattern starts to form at around 85% of the
regular mitochondrial volume, which is when the total
volume of the mitochondria is about 6% of the cytoplas-
mic volume. If the volume of functioning mitochondria is
lower than this limit, insufficient ATP is produced to
allow the insulin burst. In the burst formation category
(Additional file 1: Figure 2) each burst consists of a small
number of spikes in plasma membrane voltage, cytoplas-
mic calcium ion concentration, and the insulin secretion
rate. If the mitochondrial volume fraction is increased
beyond the value used in the standard model, the behavior
of the burst begins to change in pattern, entering the burst
loss category (Additional file 1: Figure 3). In the burst loss
category every other burst decreases in duration until it is
lost completely, while the remaining bursts lengthen their
duration. The net effect is a decrease in the fraction of
time spent in each burst.
When the volume fraction of the mitochondria rises
over about 0.095 the oscillation patterns undergo a radical
alteration (Additional file 1: Figure 4). The frequency of
the cell membrane voltage oscillation within the bursts
becomes very large. While the membrane voltage con-
tinues to undergo bursts of rapid oscillations separated by
periods of no oscillation, this no longer drives the calcium
ion concentration, which then normally drives the insulin
secretion. Thus this behavior will be called the decoupling
Table 1 The coordinates of the neighbors of the cell with
coordinates (a, b, c)
Layer Coordinates (x, y, z)
(a − 1, b, c)
Upper Layer (a − 1, b + 1, c + 1)
(a − 1, b, c + 1)
(a, b, c − 1)
(a, b, c + 1)
Same Layer (a, b − 1, c − 1)
(a, b − 1, c)
(a, b + 1, c)
(a, b + 1, c + 1)
(a + 1, b − 1, c − 1)
Lower Layer (a + 1, b, c − 1)
(a + 1, b, c)
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category. While insulin release does undergo a long and
slow periodic variation, the rapid spikes that characterize
the normal burst no longer occur.
In order to quantify the development and eventual loss
of the bursting behavior, define the “bursting fraction” as
the portion of the total time taken up by the bursts, where
a burst duration is defined as the time from the first to the
last peak in a burst. Bertram’s single cell original model
has a bursting fraction of approximately 0.55 (meaning
that a burst in the model variables’ oscillations is occurring
for 55% of the time). When the cell mitochondrial volume
fraction is changed, this bursting fraction changes mark-
edly (cf. Figure 4), and the patterns of the calcium ion con-
centration Ca2+, the cell membrane potential V, and the
insulin secretion rate I all alter noticeably. Figure 4 shows
the ranges of the mitochondrial volume ratios correspond-
ing to the four classifications: burst formation, periodic
bursts, burst loss, and decoupling. Since the classifications
are qualitative, the divisions between the classifications are
blurred and the ranges are drawn overlapping. The mem-
brane voltage, calcium ion concentration, and insulin
release all have nearly identical bursting fractions for the
first three categories (formation, periodic busts, and loss).
In the decoupling category the bursting fractions in the
calcium ion concentration and insulin release rapidly fall
to zero, while the voltage bursting fraction holds relatively
constant. The normal bursting behavior of the single
b-cell model occurs only within a narrow range of mito-
chondrial volumes, from roughly 7% to 8% of the cellular
volume.
The reason for the absence of the bursting function for
low mitochondrial volume is straightforward. With a
lower volume of functioning mitochondria the cytoplasmic
ATP levels are lower and are insufficient to trigger the
remaining stages of the signaling pathway for insulin
release (Figure 1). The change in behavior at higher mito-
chondrial volumes, where cytoplasmic ATP levels are
slightly higher, has a more complex mechanism. This
model of the insulin secretion is built around a fast central
oscillator [10,38,39] consisting of the plasma membrane
potential V and the fraction n of open delayed rectifying
potassium ion channels, denoted by K+ in Figure 1. As the
symbol implies, the opening and closing of these potas-
sium channels is controlled by the cytoplasmic ATP con-
centration. During the bursts these two variables execute a
fast oscillation (Figure 5), which drives the other oscilla-
tions of this model system. Between bursts, this oscillation
stops and the V and n values move over to the “tail of the
Q” in Figure 4, until the next burst begins. The period
of this central oscillator driving the whole model is
Figure 4 Bursting fraction for the cell membrane potential V , the calcium ion concentration Ca2+, and the insulin secretion rate I. The
X-axis represents the ratio of functional mitochondrial volume and the cytoplasmic volume. The Y-axis represents the bursting fraction.
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controlled by the ATP dependence on the opening of the
potassium channels. Higher ATP levels lead to a faster
oscillation of V and n, which (in this model) becomes too
fast for the dynamics of the cytoplasmic calcium ion con-
centration to follow, decoupling the rest of the system
from the central oscillator. Therefore, altering the mito-
chondrial/cytosol volume ratio in the model, which corre-
sponds to the amount of functional mitochondria in the
cell, alters the amount of ATP production and through
this the level and pattern of insulin secretion. In order to
reflect cell differences, the value of  is different for each
cell in the 3-D structure, with all other cell parameters
being the same.
The insulin bursts are totally absent when the volume
fraction of the mitochondria is either less than 0.06 or
greater than 0.095, which suggests an alternative definition
for “healthy cell” and “unhealthy cell”. Define a healthy
cell as having a mitochondria volume fraction  between
0.06 and 0.095, and a cell with  out of this range as an
unhealthy cell. It is plausible that some mitochondria lose
their function, effectively resulting in a smaller . The
ensuing numerical experiments use  = 0.05 for unhealthy
cells and the standard value  = 0.0733 for healthy cells.
Multiple b-cells simulation
Although there are about 1,000 cells in each pancreatic
islet, for multiple b-cells simulations, consider first the
case with 125 cells coupled spatially in a 3-D hexagonal
lattice. The justification for using 125 rather than 1000
cells is a pragmatic one–the CPU time for simulating
1,000 cells is rather long. In a 1,000 cell heterogeneous
model, each single cell model has ten variables, yielding a
10,000-dimensional ODE, which required 26 hours to
solve till time t = 2 × 106. Furthermore, the oscillation pat-
terns observed from 125 cells are qualitatively very similar
to those observed from 1,000 cells.
If there are no unhealthy cells at all, the membrane
potentials of all the cells synchronize after the coupling is
turned on at time 400,000 milliseconds (ms) by changing
gc from 0 to 150. This simulation of 125 cells without
unhealthy cells is shown in Figures 1 (membrane potential)
and 2 (total insulin secretion) in Additional file 2. The
curves in the membrane potential plot are out of phase at
time t = 0, but soon after 400,000 ms, these curves coalesce
(see Additional file 2: Figure 1). Because the insulin levels
of some cells are high while those of other cells are low,
the total insulin is relatively flat before synchronization.
Immediately after the coupling is turned on, the total insu-
lin secretion shows bursts and its value rises to a hundred
times that of a single cell, because there are more than a
hundred cells synchronized and releasing insulin in phase.
Focus on total insulin secretion to see how unhealthy
cells, through the 3-D coupling in the hexagon structure,
affect the total insulin secretion. To save computational
time the coupling is turned on at the beginning of the
simulations, t = 0. Figure 3 in Additional file 2 shows the
resulting total insulin behavior with 10% of the cells
being unhealthy spread uniformly in the 3-D hexagonal
structure. The total insulin, as in the case of 100% healthy
cells, shows periodic oscillations and maintains a reason-
able level. When the percent of cells being unhealthy
increases to 15%, the oscillations of total insulin still look
normal (see Additional file 2: Figure 4), but now some
bursts have fewer spikes. As the percentage of cells being
unhealthy increases to 20% and 30% from 10% and 15%
of cells being unhealthy, the spikes within each burst
become much less numerous (shown in Additional file 2:
Figures 5 and 6). These bursts are also much more irre-
gular, and even more significantly, totally disappear after
2.25 × 106 ms (Additional file 2: Figure 6). In summary,
the cohort of unhealthy cells dominates the global beha-
vior, resulting in a level of total insulin too low to main-
tain proper pancreatic islet function. The conclusion is
that if there is more than approximately 15% of cells
being unhealthy, the function of the pancreatic islet will
be severely affected.
To verify the conclusions from simulations with 125
cells, simulations were also performed for the model with
1,000 cells. This 1000 cell model cannot be run to as long
a time as the 125 cell model, but observe that when, for a
certain time, insulin secretion cannot generate enough
spikes, the pancreatic islet can be considered to be mal-
functioning. Hence the simulation monitors the numbers
of spikes in the last five bursts, and if the mean number of
spikes is below three, deems that the overall system is mal-
functioning and halts. The simulations for 1,000 cells with
30%, 20%, 15% of cells being unhealthy, all considered
malfunctioning systems, are shown in Figures 7, 8, and
9 of Additional file 2 respectively. A simulation for 10% of
cells being unhealthy found no malfunction in an extre-
mely long time (comparable to the time for the 125 cell
model runs). In summary, the 125 cell and 1000 cell simu-
lations yield similar conclusions: If the percentage of cells
being unhealthy is larger than approximately 15%, the sys-
tem will malfunction; at 15% of cells being unhealthy, the
system still functions but is close to malfunctioning; below
10% of cells being unhealthy, the system can definitely
function very well.
Another ratio, the number of links between an
unhealthy cell and a healthy cell to the total number of
links between all cells, is also calculated for each simula-
tion; the value of this ratio is quite close to the number
of unhealthy cells to total number of cells ratio, see
Table 2. Therefore, for further analysis, using 125 cells
and the ratio of number of unhealthy cells to total num-
ber of cells should suffice.
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Simplified multiple b-cells simulation
In order to understand further how unhealthy cells affect
the healthy cells, consider a simplified case with only one
unhealthy cell in the 3-D structure, as shown in Figure 6.
The red dot represents the unhealthy cell, the blue dots
healthy cells. The unhealthy cell is connected with all the
healthy cells, while the healthy cells themselves are con-
nected through three rings corresponding to three layers
in the 3-D structure. The experiment starts with two
cells, one healthy and one unhealthy. Then the number
of healthy cells is increased one by one. If the total num-
ber of cells is smaller than 13, the corresponding sub-
graph of Figure 6 is used. Figure 1 in Additional file 3
shows the total insulin of one unhealthy cell and one
healthy cell (coupling starts at 3 × 105 ms). According to
the “malfunction criterion” (the average number of spikes
in the last five bursts is smaller than three), the system
malfunctions. Figure 2 in Additional file 3 shows the
total insulin for one unhealthy cell and three healthy
cells. The simulations show that when the number of
healthy cells reaches three (marginally) or four, the total
insulin shows functioning bursts. This suggests that one
unhealthy cell needs at least four healthy cells to make
the whole system function well based on the topology in
Figure 6. To study the case of two unhealthy cells with
exactly the same topology and connected to the same
number of healthy cells, the topology in Figure 7 is used.
The number of healthy cells needed to rescue two
unhealthy cells is eight (marginally) or nine, which is con-
sistent with the result of one unhealthy cell in Figure 6.
Therefore one unhealthy cell needs at least four healthy
cells to make the overall system function well, i.e., the sys-
tem probably can tolerate at most 20% of cells being
unhealthy. This result matches with the previous simula-
tions with 125 and 1,000 cells in the 3-D topology.
The cause of insulin secretion failure
To study possible reasons for the failure of insulin secre-
tion caused by unhealthy cells, consider a 2 × 2 × 2
model of eight cells, in which three unhealthy cells are
uniformly distributed. Figures in Additional file 4 show
the behaviors of all the variables in this model for each of
Figure 5 Phase plane showing relationship between plasma membrane potential V an activation variable for the delayed rectifying K+
channels n. The X-axis represents the fraction of open delayed rectifying K+ATP channels. The Y-axis represents the membrane potential with a
unit of mV.
Table 2 Comparison of Two Different Ratios
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the eight cells in each figure. The insulin secretion starts
to fail at around time 2 × 105 ms as shown in Figure 8.
Except for the plot of [G6P] (see Additional file 4: Figure
10), it is hard to distinguish healthy cells from unhealthy
cells in all the plots, such as that of membrane potential
in Figure 5 of Additional file 4. In Figure 10 of Additional
file 4 eight curves are partitioned into two groups. The
upper group consists of healthy cells, while the lower one
consists of unhealthy cells. These two groups of curves
do not intersect with each other after the failure, but they
are mixed together before the failure. This observation
suggests that G6P might be closely related to the insulin
secretion failure. In order to test this hypothesis, the two
groups of curves were manually reset to see whether
insulin secretion can be reinstated: if the insulin secretion
fails for 5 × 105 ms, the values of [G6P] in all cells are
reset to 279, the initial value of [G6P] used in the simula-
tion. The oscillations of insulin secretion are resumed
(see Additional file 5: Figures 1 and 2). The black vertical
lines in these figures are the times when the values of
[G6P] are equalized. The results show that the divergence
of the two groups of [G6P] leads to the disappearance of
insulin secretion oscillations.
Since an unhealthy cell has a smaller mitochondria/
cytosol volume ratio than that of a healthy cell, unhealthy
cells usually have lower ATP (from oxidative phosphoryla-
tion) levels. ATP has a negative feedback to phosphofructo-
kinase (PFK) in glycolysis. When the ATP level is lower,
the PFK reaction becomes faster, which directly consumes
G6P faster leading to lower G6P levels in unhealthy cells
than in healthy cells. As shown in Figure 10 of Additional
file 4 the levels of G6P in healthy cells are higher than
those in unhealthy cells. At the same time, because of the
low production rate of ATP in unhealthy cells, the ratio of
ATP to ADP gets lower. ATP-sensitive K+ channels in the
plasma membrane are activated by ADP and inactivated by
ATP, so the ratio of these nucleotides determines the frac-
tion of open ATP-sensitive K+ channels. When the ATP/
ADP ratio is low there is an increase in the number of
open ATP-sensitive K+ channels, which results in the diffi-
culty of membrane depolarization. Voltage-dependent Ca2+
channels are blocked. Since the insulin is secreted when
Ca2+ exceeds a certain level, the blocked Ca2+ channels will
reduce insulin secretion. Therefore, raising the levels of
G6P in unhealthy cells back to normal will bring back nor-
mal insulin secretion. This analysis suggests the hypothesis
that increasing the value of any substance ahead of the
ATP synthesis in the pathway, such as the substances FBP
and NADH in mitochondria, reinstates the oscillations.
Manually resetting the values of either [FBP] or [NADH]
Figure 6 Topology for one unhealthy cell. A simplified case with only one unhealthy cell in the 3-D structure. The red dot (center dot)
represents the unhealthy cell, the blue dots are healthy cells.
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Figure 7 Topology for two unhealthy cells. The simplified topology for two adjacent unhealthy cells in two layers.
Figure 8 Insulin secretion failure of the eight cells system. There are three unhealthy cells uniformly distributed in the 2 X 2 X 2 topology
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in all the cells to the same initial value confirms the conjec-
ture: not only can G6P restart the insulin oscillations, but
also FBP and NADHm can restart the oscillations.
Since G6P and FBP are both substances in the glycolysis
pathway, if the rate of glycolysis were faster, the oscillations
of insulin might be resumed as well. In order to test this
conjecture, the glucokinase level is raised fourfold after the
insulin failure is detected. Glucokinase is the enzyme that
phosphorylates glucose to glucose-6-phosphate (G6P).
Figures 3 and 4 in Additional file 5 show that the oscilla-
tions of insulin are resumed when the glucokinase level
increased. Two oscillation periods are shown in Figure 5 of
Additional file 5 (from the earlier 125 cell model): The
longer period (slow oscillations) is caused by the glycolytic
oscillations, while Ca2+ feedback is responsible for the fast
oscillations. Only the short period remains in Figure 6 of
Additional file 5. This observation suggests that if the
longer period could be reestablished in Figure 6 of Addi-
tional file 5 the insulin oscillations might be reinstated.
Since the glycolysis pathway is responsible for the slow
oscillations, that pathway may need some stimulus. The
simulation results in Figures 4 and 5 of Additional file 5
demonstrate that by increasing the glucokinase level in the
glycolysis pathway, the insulin oscillations can be resumed
after the failure.
Figure 7 in Additional file 5 shows the simulation result
when the three unhealthy cells are placed together in the
2 × 2 × 2 grid. With a high ratio of unhealthy cells to total
cells (more than .20), the insulin secretion fails. If the glu-
cokinase level in the unhealthy cells is raised fourfold and
then kept unchanged during the simulation, the total insu-
lin secretion becomes normal (see Additional file 5: Figure
8). From Figure 9 in Additional file 5 all the unhealthy
cells look like the healthy cells. Even though those
unhealthy cells are still unhealthy, if their glucokinase
levels are high enough, the overall behavior of the system
will be dominated by the healthy cells. If there is no
healthy cell, only unhealthy cells with high glucokinase
levels, the system can’t be repaired, see Figure 9. There-
fore, the unhealthy cells are rendered harmless by high
glucokinase level and other healthy cells in the network.
Conclusion
In conclusion, the insulin secretion of pancreatic islets
usually will be functionally destroyed when there are more
than 20% of cells being unhealthy among all cells. The
more unhealthy cells there are, the more irregular insulin
secretion will be. Increasing the level of glucokinase can
make the pancreatic islet function normally when there is
a high fraction of unhealthy cells by increasing the glucose
absorption of the glycolysis pathway. This has implications
for the clinical treatment of type II diabetes. Currently
there are three classes of medications used to treat type II
diabetes. The first treatment is to increase the amount of
insulin secreted by the pancreas by inhibiting the opened
delayed rectifying K+ channels. The second treatment is to
Figure 9 Total insulin secretion of the eight unhealthy cells system with the stimulation on glucokinase of the cells. All the cells are
placed in the 2 × 2 × 2 topology.
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increase the sensitivity of target organs to insulin. The
third treatment is to decrease the rate at which glucose is
absorbed from the gastrointestinal tact, which is a method
to reduce the glucose uptake from food. It appears that all
the available treatments are insufficient to stem the tide.
Therefore, new treatments are currently under investiga-
tion including the development of therapeutic agents with
novel action mechanisms. Recently, researchers have iden-
tified glucokinase as an outstanding drug target for devel-
oping antidiabetic medicines [25-30]. Assuming the
mathematical models are valid, the simulation results
demonstrate that stimulating glucokinase can make
unhealthy pancreatic islets function normally, consistent
with new antidiabetic medicines. Such multiple cell mod-
els are good candidates for guiding the development of the
next generation of antidiabetic medicines.
Additional material
Additional file 1: Cell membrane potential, calcium and insulin
oscillation plots illustrating the different burst domain. Contains cell
membrane potential, calcium and insulin oscillation plots illustrating the
periodic bursting domain, burst formation domain, burst loss domain
and decoupling domain.
Additional file 2: Multiple cells simulation. The simulation results of
125 cells and one thousand cells with different percentages of unhealthy
cells.
Additional file 3: Simplified multiple cells simulation. The simulation
results of the simplified multiple cells model.
Additional file 4: The behaviors of all the variables in eight cells
model. Figures that show the behaviors of all the variables in eight cells
model for each of the eight cells.
Additional file 5: Reinstate oscillations of insulin secretion. Figures
that demonstrate the reinstatement of insulin secretion by increasing
level of G6P and glucokinase.
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